Publications
Just-In-Time in Community-Based Practices
Accelerating Oncology Clinical Trial Enrollment in Community-Based Practices: Just-In-Time Approach
PCR Treatment in Stage III/IV NHL
A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of Pentostatin, Cytoxan, and Rituxan (PCR) in the Treatment of Previously Untreated or Treated, Stage III or IV, Low-Grade B-Cell Non-Hodgkin’s Lymphoma (NHL) or Bulky Stage II Lymphoma
Just-In-Time Approach
Revolutionizing Oncology Patient Enrollment in Clinical Trials: Just-In-Time Approach
Pentostatin and Rituximab for CLL or Low-Grade B-Cell NHL
Enhanced Safety and Tolerability of Dose Intensive Pentostatin and Rituximab in Patients with CLL or Low-Grade B-Cell NHL